Publications by authors named "Johana Uribe"

Organic electrochemical transistors have emerged as a promising alternative to traditional 2/3 electrode setups for sensing applications, offering in-situ transduction, electrochemical amplification, and noise reduction. Several of these devices are designed to detect potentiometric-derived signals. However, potentiometric sensing should be performed under open circuit potential conditions, allowing the system to reach thermodynamic equilibrium.

View Article and Find Full Text PDF
Article Synopsis
  • Tumor-derived extracellular vesicles (TEVs) promote invasive cancer traits by inducing epithelial-to-mesenchymal transition (EMT) in healthy cells, highlighting a new area for cancer treatment.
  • A new screening platform using organic electrochemical transistors (OECTs) enables real-time monitoring of TEV effects and the testing of drugs that can inhibit metastasis.
  • The study identifies heparin as an effective blocker of TEV-induced EMT, demonstrating the platform's potential for drug discovery aimed at reducing cancer spread.
View Article and Find Full Text PDF

Cancer-derived exosomes (cEXOs) facilitate transfer of information between tumor and human primary stromal cells, favoring cancer progression. Although the mechanisms used during this information exchange are still not completely understood, it is known that binding is the initial contact established between cEXOs and cells. Hence, studying binding and finding strategies to block it are of great therapeutic value.

View Article and Find Full Text PDF

Extracellular vesicles (EVs) are membrane-encapsulated particles secreted by eukaryotic cells that stimulate cell communication and horizontal cargo exchange. EV interactions with stromal cells can result in molecular changes in the recipient cell and, in some cases, lead to disease progression. However, mechanisms leading to these changes are poorly understood.

View Article and Find Full Text PDF

Calcific aortic valvular disease (CAVD) is the most prevalent valvular pathology in the United States. Development of a pharmacologic agent to slow, halt, or reverse calcification has proven to be unsuccessful as still much remains unknown about the mechanisms of disease initiation. Although in vitro models of some features of CAVD exist, their utility is limited by the inconsistency of the size and time course of the calcified cell aggregates.

View Article and Find Full Text PDF